Skip to content
The Nexus
DossierENTITY

hair loss drugs

Coverage of hair loss drugs in the Nexus archive.

Earliest in view: Jun 25 · 18:58 UTCMost recent: Jun 25 · 18:58 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJun 25 · 18:58 UTCSTAT NEWS
    The mysterious case of Eli Lilly’s obesity drug

    Eli Lilly's obesity drug retatrutide is being made available to one individual through the FDA's 'compassionate use' program. The article discusses this development alongside broader questions about drugmaker acquisitions and the investment potential of hair loss drugs, as covered in a podcast episode.